Lundbeck
HLUN-B.CO
#2582
Rank
HK$41.75 B
Marketcap
HK$43.82
Share price
-0.98%
Change (1 day)
18.12%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): HK$3.61 Billion

According to Lundbeck 's latest financial reports the company's current earnings are HK$3.14 Billion. In 2023 the company made an earning of HK$3.43 Billion, an increase over its 2022 earnings that were of HK$2.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.61 B5.39%
2023 HK$3.43 B21.69%
2022 HK$2.81 B31.79%
2021 HK$2.13 B-4.53%
2020 HK$2.24 B-45.08%
2019 HK$4.08 B-33.97%
2018 HK$6.17 B12.76%
2017 HK$5.48 B94.32%
2016 HK$2.82 B-136.98%
2015 -HK$7.63 Billion-1258.1%
2014 HK$0.65 B-72.43%
2013 HK$2.38 B4.31%
2012 HK$2.28 B-55.26%
2011 HK$5.11 B6.64%
2010 HK$4.79 B-6.68%
2009 HK$5.14 B